DIEBOLD NIXDORF, Inc (DBD) earnings date, results and what the price requires
NYSE · SEC CIK 0000028823 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $930.8M | $15.5M | $0.44 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $891.8M | $5.0M | $0.14 | Filing |
| Dec 31, 2025 | Feb 12, 2026 | $1.10B | $49.6M | $1.32 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | $945.2M | $41.1M | $1.11 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | $915.2M | $12.2M | $0.33 | Filing |
| Mar 31, 2025 | May 7, 2025 | $841.1M | $-8.3M | $-0.22 | Filing |
| Dec 31, 2024 | Feb 12, 2025 | $988.9M | $5.6M | $0.15 | Filing |
| Sep 30, 2024 | Nov 7, 2024 | $927.1M | $-22.4M | $-0.60 | Filing |
What would DIEBOLD NIXDORF, Inc have to report for its valuation to change?
At $66.57, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 13.6% a year, to $5.69. On that path the next quarter needs diluted EPS near $1.26, against $1.11 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 13.6% | 13.6% |
| EPS needed in final year | $5.69 | $5.69 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. DBD goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.